Histologic Antibody-mediated Kidney Allograft Rejection in the Absence of Donor-specific HLA Antibodies
- 23 April 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 105 (11) , e181-e190
Abstract
Histologic antibody-mediated rejection (hAMR) is defined as a kidney allograft biopsy satisfying the first 2 Banff criteria for diagnosing AMR: tissue injury and evidence of current/recent antibody interaction with the endothelium. In approximately one-half of such cases, circulating human leukocyte antigen (HLA) donor-specific antibodies (DSA) are not detectable by current methodology at the time of biopsy. Some studies indicated a better prognosis for HLA-DSA-negative cases of hAMR compared to those with detectable HLA-DSA, whereas others found equally poor survival compared to hAMR-negative cases. We reviewed the literature regarding the pathophysiology of HLA-DSA-negative hAMR. We find 3 nonmutually exclusive possibilities: (1) HLA-DSA are involved, but just not detected; (2) non-HLA-DSA (allo or autoantibodies) are pathogenically involved; and/or (3) antibody-independent NK cell activation is mediating the process through “missing-self” or other activating mechanisms. These possibilities are discussed in detail. Recommendations regarding the approach to such patients are made. Clearly, more research is necessary regarding the measurement of non-HLA antibodies, recipient/donor NK cell genotyping, and the use of antibody reduction therapy or other immunosuppression in any subset of patients with HLA-DSA-negative hAMR.Keywords
This publication has 105 references indexed in Scilit:
- Role of anti-vimentin antibodies in allograft rejectionHuman Immunology, 2013
- Potential Impact of Microarray Diagnosis of T Cell–Mediated Rejection in Kidney Transplants: The INTERCOM StudyAmerican Journal of Transplantation, 2013
- Major histocompatibility complex class I–related chain A allele mismatching, antibodies, and rejection in renal transplantationHuman Immunology, 2011
- Antibodies Reactive to Non-HLA Antigens in Transplant GlomerulopathyJournal of the American Society of Nephrology, 2011
- Natural Killer Cell Education and ToleranceCell, 2010
- Peripheral blood B cells producing donor-specific HLA antibodies in vitroHuman Immunology, 2009
- Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene ExpressionPLOS Genetics, 2008
- Epitope recognition by a DPα chain-specific monoclonal antibody (DP11.1) is influenced by the interaction between the DPα chain and its polymorphic DPβ chain partnerHuman Immunology, 1988
- SEROLOGICAL CHARACTERIZATION OF ANTIBODIES ELUTED FROM CHRONICALLY REJECTED HUMAN RENAL ALLOGRAFTSTransplantation, 1981
- Immunological studies on eluates from human kidney graftsClinical Immunology and Immunopathology, 1975